Apply For a Grant

METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.

2022 Grant Cycle - NOW OPEN

METAvivor Translational Research Award: Up to 2 years, $250,000 award for established investigators.

Application Portal Opens: February 9, 2022
Required Letter of Intent Due: by 11:59 PM ET on March 25, 2022
Invitations to Submit Full Application Sent: on or by June 1, 2022
Invited Applications Due: by 11:59 PM ET on August 23, 2022
Announcement of Awardees: on or by December 14, 2022

METAvivor Early Career Investigator Award: Up to 2 years, $100,000 award available to early career applicants (investigators within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started).

Application Portal Opens: February 9, 2022
Required Letter of Intent Due: by 11:59 PM ET on March 20, 2022
Invitations to Submit Full Application Sent: on or by June 1, 2022
Invited Applications Due: by 11:59 PM ET on August 23, 2022
Announcement of Awardees: on or by December 14, 2022

 

Apply Now

 

METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.

Thank you for your interest and participation.